Multimer Detection System-Oligomerized Amyloid Beta (MDS-OA<i>β</i>): A Plasma-Based Biomarker Differentiates Alzheimer’s Disease from Other Etiologies of Dementia

<div>Comparison of the mean and 95% CI of MDS-OA<i>β</i> per clinical diagnosis.</div>

International Journal of Alzheimer’s Disease

fig2

Figure 2

Figure 2: Multimer Detection System-Oligomerized Amyloid Beta (MDS-OA<i>β</i>): A Plasma-Based Biomarker Differentiates Alzheimer’s Disease from Other Etiologies of Dementia 

Figure 2 | Multimer Detection System-Oligomerized Amyloid Beta (MDS-OAβ): A Plasma-Based Biomarker Differentiates Alzheimer’s Disease from Other Etiologies of Dementia 